Lynch Syndrome from a surgeon perspective: Retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years old

BMC Surgery

Volumn 14, Issue 1, 2014, Pages

  Baiocchi, Gian Luca ^a   Portolani, Nazario ^a   Vermi, William ^a   Baronchelli, Carla ^a   Gheza, Federico ^a   Zogno, Claudio ^a   Scaglia, Alessandro ^a   Marchina, Eleonora ^a   Tiberio, Guido Am ^a   Giulini, Stefano Maria ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; G T MISMATCH BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; COLON RESECTION; COLORECTAL TUMOR; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; FEMALE; FOLLOW UP; GENETICS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDY; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COLECTOMY; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84899491370     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-14-9     Document Type: Article

References (26)

1. Hereditary factors in cancer. Study of two large midwestern kindreds. Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ, Arch Intern Med 1966 117 206 212 10.1001/archinte.1966.03870080050009 5901552
2. AGA technical review on hereditary colorectal cancer and genetic testing. Giardiello FM, Brensinger JD, Petersen GM, Gastroenterology 2001 121 198 213 11438509
3. Genetic susceptibility to non-polyposis colorectal cancer. Lynch HT, de la Chapelle A, J Med Genet 1999 36 801 818 10544223
4. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomäki P, Mecklin JP, Järvinen HJ, Int J Cancer 1999 81 214 218 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L 10188721
5. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, Buchanan DD, Clendenning M, Giles GG, Winship I, Macrae FA, Goldblatt J, Southey MC, Arnold J, Thibodeau SN, Gunawardena SR, Bapat B, Baron JA, Casey G, Gallinger S, Le Marchand L, Newcomb PA, Haile RW, Hopper JL, Jenkins MA, J Clin Oncol 2012 30 958 964 10.1200/JCO.2011.39.5590 22331944
6. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Vasen HF, Mecklin JP, Khan PM, Lynch HT, Dis Colon Rectum 1991 34 424 425 10.1007/BF02053699 2022152
7. Familial colonic cancer without antecedent polyposis. Boland CR, Troncale FJ, Ann Intern Med 1984 100 700 701 10.7326/0003-4819-100-5-700 6712034
8. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Nature 1994 371 75 80 10.1038/371075a0 8072530
9. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R, Cell 1993 75 1027 1038 10.1016/0092-8674(93) 90546-3 8252616
10. Germ-line msh6 mutations in colorectal cancer families. Kolodner RD, Tytell JD, Schmeits JL, Kane MF, Gupta RD, Weger J, Wahlberg S, Fox EA, Peel D, Ziogas A, Garber JE, Syngal S, Anton-Culver H, Li FP, Cancer Res 1999 59 5068 5074 10537275
11. Cancer risk associated with germline DNA mismatch repair gene mutations. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B, Hum Mol Genet 1997 6 105 110 10.1093/hmg/6.1.105 9002677
12. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ, American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee, Gastroenterology 2008 134 1570 1595 10.1053/j.gastro.2008.02.002 18384785
13. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. Marra G, Boland CR, J Natl Cancer Inst 1995 87 1114 1125 10.1093/jnci/87.15.1114 7674315
14. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Vasen HF, Watson P, Mecklin JP, Lynch HT, Gastroenterology 1999 116 1453 1456 10.1016/S0016-5085(99)70510-X 10348829
15. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S, J Natl Cancer Inst 1997 89 1758 1762 10.1093/jnci/89.23.1758 9392616
16. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE, J Med Genet 2000 37 641 645 10.1136/jmg.37.9.641 10978352
17. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C, Gastrointestinal Consortium Panel, Gastroenterology 2003 124 544 560 10.1053/gast.2003.50044 12557158
18. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N, JAMA 2006 29 1507 1517
19. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I, Lipton L, Young GP, Young JP, Lodge CJ, Southey MC, Newcomb PA, Le Marchand L, Haile RW, Lindor NM, Gallinger S, Hopper JL, Jenkins MA, Lindor NM, Petersen GM, Hadley DW, Gut 2011 60 950 957 10.1136/gut.2010.228056 21193451
20. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, J Natl Cancer Inst 2012 104 1363 1372 10.1093/jnci/djs351 22933731
21. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM, Ann Intern Med 1998 129 787 796 10.7326/0003-4819-129-10-199811150-00007 9841584
22. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Warrier SK, Trainer AH, Lynch AC, Mitchell C, Hiscock R, Sawyer S, Boussioutas A, Heriot AG, Dis Colon Rectum 2011 54 1480 1487 10.1097/DCR.0b013e318231db1f 22067175
23. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Shia J, Tang LH, Vakiani E, Guillem JG, Stadler ZK, Soslow RA, Katabi N, Weiser MR, Paty PB, Temple LK, Nash GM, Wong WD, Offit K, Klimstra DS, Am J Surg Pathol 2009 33 1639 1645 10.1097/PAS.0b013e3181b15aa2 19701074
24. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Lothe RA, Peltomäki P, Meling GI, Aaltonen LA, Nyström-Lahti M, Pylkkänen L, Heimdal K, Andersen TI, Møller P, Rognum TO, Cancer Res 1993 53 5849 5852 8261392
25. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, Young JP, Barker MA, Jass JR, Hopper J, Gallinger S, Bapat B, Redston M, Thibodeau SN, J Clin Oncol 2002 20 1043 1048 10.1200/JCO.20.4.1043 11844828
26. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. Hendriks YM, de Jong AE, Morreau H, Tops CM, Vasen HF, Wijnen JT, Breuning MH, Bröcker-Vriends AH, CA Cancer J Clin 2006 56 213 225 10.3322/canjclin.56.4.213 16870997